March 28th 2024
Tenofovir alafenamide was approved in 2022 to treat pediatric patients aged 12 years and older.
2024 USCAP Satellite Symposia
March 25-27, 2024
Register Now!
FAQs in Peanut Allergy: Exploring Unanswered Questions Following Allergy Meeting Updates
View More
FAQs in MS: Exploring Provocative Questions From MS Meeting Updates
View More
BURST CME™: Taking ALS Management to the Next Level
View More
What’s in Your Basket? Tumor Agnostic Trials and the Reshaping of Precision Medicine in Oncology: A Focus on TSC1/2 Mutations
View More
Medical Crossfire®: Why is PSMA so Effective? To Affinity and Beyond
View More
Expert Illustrations and Commentaries™: Evaluating the Potential for Novel Mechanistic Approaches to Overcome Clinical Gaps in the Care of Patients with LR-MDS
View More
Community Practice Connections™: Guidebook for Community Oncology NSCLC Treating Teams to Administer EGFR Exon 20-Targeted Regimens
View More
FDA approves rilpivirine for pediatric patients with HIV-1, weighing 14 kg to 25 kg
March 20th 2024Administration of the HIV-1 specific, non-nucleoside reverse transcriptase inhibitor (NNRTI) to the indicated population can be done via 25 mg oral tablets or new 2.5 mg oral tablets, developed to help administration and weight-adjusted dosing for children.
Twiist automated insulin delivery system FDA cleared for children 6 years and up with T1D
March 18th 2024Integrated data from a continuous glucose monitoring device (CGM) and an insulin pump to automate insulin delivery allow AID systems to manage patient blood sugar levels more "effectively," according to Sequel.
Mothers with high BMI less likely to breastfeed
March 15th 2024Mothers who are overweight or obese are more likely to breastfeed for shorter durations or not breastfeed at all when compared to mothers of normal weight, according to new research presented in a poster session at the NAPNAP 2024 National Conference on Pediatric Health Care in Denver, Colorado.